NIH unit awards $6.5M grant to Dana-Farber for vaccine research

08/15/2010 | Mass High Tech (Boston)

The National Institute of Allergy and Infectious Diseases, a division of the NIH, has awarded a $6.5 million grant to Dana-Farber Cancer Institute to help it develop a universal T cell-based vaccine against influenza A viruses. "Our ultimate goal is a vaccine that targets the conserved viral segments that cannot vary from one viral strain to another, thereby providing protection against all seasonal and pandemic flus," said Ellis Reinherz, the study's principal investigator.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX